These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4006181)

  • 1. On the natural history of hypergastrinemia.
    Lindstedt G; Runsteen D; Lundberg PA; Bengtsson C; Lapidus L; Nyström E; Kilander AF
    Clin Chem; 1985 Jul; 31(7):1135-40. PubMed ID: 4006181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a test meal on serum group I pepsinogens (PG I) and serum gastrin in persons with normal gastric H+ secretion and in persons with achlorhydria.
    Waldum HL; Jorde R; Burhol PG
    Scand J Gastroenterol; 1980; 15(3):267-71. PubMed ID: 7433884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypergastrinemia--a risk factor for myocardial infarction?
    Lindstedt G; Bengtsson C; Lapidus L; Nyström E
    Clin Chem; 1985 Apr; 31(4):585-90. PubMed ID: 3978791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.
    Jansen JB; Klinkenberg-Knol EC; Meuwissen SG; De Bruijne JW; Festen HP; Snel P; Lückers AE; Biemond I; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):621-8. PubMed ID: 2199288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma.
    Haruma K; Yoshihara M; Sumii K; Tari A; Watanabe C; Kodoi A; Kajiyama G
    Scand J Gastroenterol; 1993 Jul; 28(7):633-7. PubMed ID: 8362219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
    Krasinski SD; Russell RM; Samloff IM; Jacob RA; Dallal GE; McGandy RB; Hartz SC
    J Am Geriatr Soc; 1986 Nov; 34(11):800-6. PubMed ID: 3771980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gastrin response to feeding in achlorhydric patients.
    Lamers CB
    Hepatogastroenterology; 1980 Jun; 27(3):217-9. PubMed ID: 7461596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the clinical significance concerning the changes in serum pepsinogen-I and gastrin levels in aged patients with chronic gastritis].
    Hamada Y; Kamiya K; Koyama M; Asaka M; Matsushima T; Myazaki T; Kamiya T
    Hokkaido Igaku Zasshi; 1988 Mar; 63(2):178-85. PubMed ID: 2898425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term administration of omeprazole on serum gastrin and pepsinogens in antrectomized patients.
    Meijer JL; Jansen JB; Biemond I; Lamers CB
    Digestion; 1993; 54(3):139-42. PubMed ID: 8359554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C.
    Iwao T; Toyonaga A; Kuboyama S; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):677-82. PubMed ID: 8751234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
    Pérez-Paramo M; Albillos A; Calleja JL; Salas C; Marín MC; Marcos ML; Cacho G; Escartín P; Ortiz-Berrocal J
    Dig Dis Sci; 1997 Aug; 42(8):1734-40. PubMed ID: 9286242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C; Vakil N; Rugge M; Gatta L; Perna F; Osborn JF; Russo VM; Tampieri A; Bernabucci V; Miglioli M; Vaira D
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and provocative tests for gastroduodenal disorders.
    Walsh JH
    J Clin Gastroenterol; 1981; 3(Suppl 2):73-8. PubMed ID: 7320472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type.
    Fukao A; Takamatsu J; Shimamoto C; Kuma K; Ohsawa N
    Thyroid; 1998 Mar; 8(3):259-63. PubMed ID: 9545113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
    Westerveld BD; Pals G; Lamers CB; Defize J; Pronk JC; Frants RR; Ooms EC; Kreuning J; Kostense PJ; Eriksson AW
    Cancer; 1987 Mar; 59(5):952-8. PubMed ID: 3815274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori.
    Oderda G; Vaira D; Dell'Olio D; Holton J; Forni M; Altare F; Ansaldi N
    J Clin Pathol; 1990 Sep; 43(9):762-5. PubMed ID: 2212069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.